BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi AppTec Completes RMB1 Billion A-Share Buyback and HKD2.5 Billion H-Share Acquisition to Drive Shareholder and Talent Value

WuXi AppTec Co., Ltd, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and ...

July 09, 2025 | News

Japanese Life Sciences Delegation Strengthens Collaboration with North Carolina’s Innovation Ecosystem

A high-level Japanese delegation specializing in life sciences concluded a three-day visit to North Carolina (June 24–26), further strengthening ties...

July 07, 2025 | News

Illumina to Acquire SomaLogic for $350 Million, Expanding Proteomics Portfolio and Advancing Multiomics Vision

Combines highly complementary proteomics expertise with Illumina’s industry-leading product innovation and global market reach Positions Illumina to...

June 24, 2025 | News

XtalPi and DoveTree Sign $100M+ LOI to Accelerate AI-Driven Drug Discovery Across Oncology and Neurology

XtalPi, a global leader in AI- and robotics-powered drug and materials discovery, announced it has signed a Letter of Intent (LOI) with DoveTre...

June 23, 2025 | News

Novo Holdings Showcases Strategic Growth and Impact in Asia with Landmark 2024 Investments

Landmark investments, portfolio progress, and expanded presence positionNovo Holdings for long-term growth and impact in Asia Novo Holdings released ...

June 20, 2025 | News

Veranova Invests Over $50M to Launch Bioconjugation Development and GMP Manufacturing in Massachusetts

Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pha...

June 19, 2025 | News

Cytiva’s $1.6B Expansion Across 3 Continents to Boost Bioprocessing Supply

Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and ...

June 12, 2025 | News

Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases

- Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapies for Cardiometabolic Diseases The partnership ai...

June 12, 2025 | News

ClavystBio and A*STAR Join Forces to Accelerate MedTech Venture Creation and Commercialisation in Singapore

ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), S...

June 11, 2025 | News

HTL Biotechnology Unveils €12M Sterile Hyaluronic Acid Unit, Strengthening France’s Biomanufacturing Leadership

HTL Biotechnology confirms its position as a globalleader in the development and production of pharmaceutical-grade biopolymers, by inauguratin...

June 09, 2025 | News

QureBio Secures Nearly CNY 100 Million in Series C1 Funding Led by Efung Capital

Qure Biotechnology (Shanghai) Co., Ltd. (QureBio) announced that it has completed a Series C1 financing round. The financing raised nearly CNY 100 mil...

June 06, 2025 | News

Quadria Capital Closes Oversubscribed $1.07B Fund III to Drive Healthcare Innovation Across India and Southeast Asia

Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia heal...

May 27, 2025 | News

Pfizer Strikes $1.25B Ex-China Licensing Deal With China’s 3SBio for Cancer Antibody SSGJ-707

Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutic...

May 20, 2025 | News

GSK Acquires Efimosfermin from Boston Pharmaceuticals in $2 Billion Deal to Advance Liver Disease Pipeline

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show ...

May 15, 2025 | News

Stay Connected